1. Home
  2. ARE vs ICLR Comparison

ARE vs ICLR Comparison

Compare ARE & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARE
  • ICLR
  • Stock Information
  • Founded
  • ARE 1994
  • ICLR 1990
  • Country
  • ARE United States
  • ICLR Ireland
  • Employees
  • ARE N/A
  • ICLR N/A
  • Industry
  • ARE Real Estate Investment Trusts
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • ARE Real Estate
  • ICLR Health Care
  • Exchange
  • ARE Nasdaq
  • ICLR Nasdaq
  • Market Cap
  • ARE 13.2B
  • ICLR 14.3B
  • IPO Year
  • ARE 1997
  • ICLR 1998
  • Fundamental
  • Price
  • ARE $55.36
  • ICLR $159.14
  • Analyst Decision
  • ARE Hold
  • ICLR Buy
  • Analyst Count
  • ARE 10
  • ICLR 15
  • Target Price
  • ARE $93.00
  • ICLR $211.36
  • AVG Volume (30 Days)
  • ARE 3.1M
  • ICLR 996.7K
  • Earning Date
  • ARE 10-27-2025
  • ICLR 10-22-2025
  • Dividend Yield
  • ARE 9.49%
  • ICLR N/A
  • EPS Growth
  • ARE N/A
  • ICLR N/A
  • EPS
  • ARE N/A
  • ICLR 7.47
  • Revenue
  • ARE $3,058,395,000.00
  • ICLR $8,102,602,000.00
  • Revenue This Year
  • ARE N/A
  • ICLR N/A
  • Revenue Next Year
  • ARE N/A
  • ICLR $0.89
  • P/E Ratio
  • ARE N/A
  • ICLR $21.29
  • Revenue Growth
  • ARE N/A
  • ICLR N/A
  • 52 Week Low
  • ARE $52.94
  • ICLR $125.10
  • 52 Week High
  • ARE $114.69
  • ICLR $228.29
  • Technical
  • Relative Strength Index (RSI)
  • ARE 25.23
  • ICLR 33.43
  • Support Level
  • ARE $52.94
  • ICLR $159.19
  • Resistance Level
  • ARE $58.70
  • ICLR $167.87
  • Average True Range (ATR)
  • ARE 2.65
  • ICLR 8.45
  • MACD
  • ARE -1.43
  • ICLR -2.75
  • Stochastic Oscillator
  • ARE 9.56
  • ICLR 4.93

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: